Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor γ, in colorectal adenocarcinoma

Peroxisome proliferator-activated receptor gamma (PPARgamma) agonists have been demonstrated to exert an inhibitory effect on cell growth, and to induce the cell differentiation and apoptosis of colorectal cancer cells. PPARgamma was therefore proposed as a therapeutic target. Recently, a variant of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology reports 2007-08, Vol.18 (2), p.489-495
Hauptverfasser:	BOUANCHEAU, Delphine, JARRY, Anne, MOTTIER, Stephanie, TOQUET, Claire, MASSON, Damien, MOSNIER, Jean-Francois, LABOISSE, Christian L, DENIS, Marc G
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - genetics Adenocarcinoma - pathology Aged Aged, 80 and over Alternative Splicing Biological and medical sciences Caco-2 Cells Cell Line, Tumor Colorectal Neoplasms - genetics Colorectal Neoplasms - pathology Female Gastroenterology. Liver. Pancreas. Abdomen Gene Expression Regulation, Neoplastic - drug effects HT29 Cells Humans Male Medical sciences Middle Aged Oxazoles - pharmacology PPAR gamma - agonists PPAR gamma - genetics Protein Isoforms - genetics Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - genetics RNA, Messenger - metabolism Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Tumors Tyrosine - analogs & derivatives Tyrosine - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!